Fred E. Cohen
Director at Kyverna Therapeutics; Director at CareDx; Director at Intellia Therapeutics. Based in Brisbane, California.
- Rank
- 6407th of 14,644
- Companies held
- 5
- Largest holding
- CDNA, 66.4% of total
- Latest SEC filing
- Nov 3, 2026
- Listed but not counted
- $19.7M
What the $15.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| CareDx CDNA Common Stock | Directly | 140,060 | $71.86 | $10.1M | 66.4% | Form 4, Nov 3, 2026 |
| UroGen Pharma URGN Ordinary Shares | Through Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer | 69,339 | $31.77 | $2.2M | 14.5% | Form 4, Jul 26, 2023 |
| Intellia Therapeutics NTLA Common Stock | Directly | 216,653 | $9.15 | $2.0M | 13.1% | Form 4, Jun 9, 2026 |
| Progyny PGNY Common Stock | Directly | 22,693 | $35.63 | $808K | 5.3% | Form 4, May 23, 2024 |
| Kyverna Therapeutics KYTX Common Stock | Directly | 21,727 | $4.35 | $95K | 0.6% | Form 4, May 27, 2026 |
Share counts are the amounts Fred E. Cohen reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Fred E. Cohen's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Kyverna Therapeutics KYTX Common Stock | Through Vida Ventures, LLC Held by a company or fund the insider manages | 4,523,924 | $4.35 | $19.7M | — | Form 4, May 27, 2026 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6404 | Brent K. Bilsland President and CEO, Hallador Energy. Terre Haute, IN | $15.2M |
| 6405 | Robert T. Newcomb Director, First Citizens BancShares. Raleigh, NC | $15.2M |
| 6406 | Ward W. Woods Jr. Director, Alphatec Holdings. Carlsbad, CA | $15.2M |
| 6407 | Fred E. Cohen Director, Kyverna Therapeutics. Brisbane, CA | $15.2M |
| 6408 | Stanley Deal EVP, Pres. & CEO, BCA, The Boeing | $15.2M |
| 6409 | David G. DeWalt Director, HawkEye 360. Atlanta, GA | $15.2M |
| 6410 | Christopher A. Graham Senior Vice President, Steel Dynamics. Fort Wayne, IN | $15.2M |
Other Kyverna Therapeutics insiders
All KYTX insiders- Peter Maag$1.8MChief Executive Officer. #4535 overall
- Beth C. Seidenberg$95KDirector. #6372 overall
Questions
How much stock does Fred E. Cohen own?
Fred E. Cohen holds $15,153,587 in listed stock based on SEC filings and current prices, mostly CareDx (CDNA). That ranks 6407th on the Stock Rich List.
Is this Fred E. Cohen's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Fred E. Cohen last buy or sell stock?
The most recent open-market trade on file is a purchase of 150,000 NTLA shares on Jan 5, 2026 at $9.35.